| Identification | Back Directory | [Name]
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(1E)-3-(6-amino-4-imino-1(4H)-pyrimidinyl)-1-propen-1-yl]-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-[[(S)-carboxy(3,4-dihydroxyphenyl)methoxy]imino]acetyl]amino]-8-oxo-, sodium salt (1:1), (6R,7R)- | [CAS]
175553-22-7 | [Synonyms]
LB10517
LB-10517
LB 10517
Antibiotic LB10517
Antibiotic LB-10517
Antibiotic LB 10517
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(1E)-3-(6-amino-4-imino-1(4H)-pyrimidinyl)-1-propen-1-yl]-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-[[(S)-carboxy(3,4-dihydroxyphenyl)methoxy]imino]acetyl]amino]-8-oxo-, sodium salt (1:1), (6R,7R)- | [Molecular Formula]
C27H26N9NaO9S2 | [MOL File]
175553-22-7.mol | [Molecular Weight]
707.67 |
| Hazard Information | Back Directory | [Description]
Antibiotic LB 10517 is a catechol-substituted cephalosporin with a broad antibacterial spectrum. | [Uses]
LB 10517 (sodium) is a type of cephalosporin. LB 10517 (sodium) has broad-spectrum antibacterial activity against both Gram-positive and Gram-negative bacteria, including Enterobacteriaceae, Pseudomonas aeruginosa, Staphylococcus, and Streptococcus[1]. | [References]
[1] Song, Hye-Kyong, et al. In vitro and in vivo evaluations of LB10517, a novel parenteral broad-spectrum cephalosporin. Archives of Pharmacal Research 19 (1996): 46-51. |
|
|